Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Erickson

Showing results (361-370 of 434) with videos related to

Pageof 44
Sort By:
Gynecologic Oncology|September 16, 2014
Diabetes mellitus and ovarian cancer: more complex than just increasing riskMonjri M Shah, Britt K Erickson, Tasnia Matin, et al.
Laboratory Animal Science|November 14, 1997
Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animalsP J O'Brien, G W Dameron, M L Beck, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 30, 2016
Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft MiceYong Ma, S Cyrus Khojasteh, Cornelis E C A Hop, et al.
BJC Reports|February 6, 2026
STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancerArpit Aggarwal, Morgann Madill, Mayukhmala Jana, et al.
Oncotarget|September 12, 2014
Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerZachary C Dobbin, Ashwini A Katre, Adam D Steg, et al.
Gynecologic Oncology|July 4, 2013
Pre-operative imaging with CA125 is a poor predictor for granulosa cell tumorsJessica E Stine, Anuj Suri, Paola A Gehrig, et al.
Molecular Cell|January 10, 2017
A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature CharacterizationBrian K Erickson, Christopher M Rose, Craig R Braun, et al.
Obstetrics and Gynecology|August 13, 2019
Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-OophorectomyAnnelise M Wilhite, Makinna C Oestreich, Megan Olson, et al.
Molecular Cancer Therapeutics|March 13, 2012
The effect of different linkers on target cell catabolism and pharmacokinetics/pharmacodynamics of trastuzumab maytansinoid conjugatesHans K Erickson, Gail D Lewis Phillips, Douglas D Leipold, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
High muscle blood flow in man: is maximal O2 extraction compromised?R S Richardson, D C Poole, D R Knight, et al.
Pageof 44

Showing results (361-370 of 434) with videos related to

Sort By:
Pageof 44
Gynecologic Oncology|September 16, 2014
Diabetes mellitus and ovarian cancer: more complex than just increasing riskMonjri M Shah, Britt K Erickson, Tasnia Matin, et al.
Laboratory Animal Science|November 14, 1997
Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animalsP J O'Brien, G W Dameron, M L Beck, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 30, 2016
Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft MiceYong Ma, S Cyrus Khojasteh, Cornelis E C A Hop, et al.
BJC Reports|February 6, 2026
STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancerArpit Aggarwal, Morgann Madill, Mayukhmala Jana, et al.
Oncotarget|September 12, 2014
Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerZachary C Dobbin, Ashwini A Katre, Adam D Steg, et al.
Gynecologic Oncology|July 4, 2013
Pre-operative imaging with CA125 is a poor predictor for granulosa cell tumorsJessica E Stine, Anuj Suri, Paola A Gehrig, et al.
Molecular Cell|January 10, 2017
A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature CharacterizationBrian K Erickson, Christopher M Rose, Craig R Braun, et al.
Obstetrics and Gynecology|August 13, 2019
Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-OophorectomyAnnelise M Wilhite, Makinna C Oestreich, Megan Olson, et al.
Molecular Cancer Therapeutics|March 13, 2012
The effect of different linkers on target cell catabolism and pharmacokinetics/pharmacodynamics of trastuzumab maytansinoid conjugatesHans K Erickson, Gail D Lewis Phillips, Douglas D Leipold, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
High muscle blood flow in man: is maximal O2 extraction compromised?R S Richardson, D C Poole, D R Knight, et al.
Pageof 44